The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation

EuroIntervention 2012;8:43-50 publish online ahead of print March 2012. DOI: 10.4244/EIJV8I1A8

1. Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Essen, Germany; 2. Department of Medicine / Cardiology, University of Bonn, Bonn, Germany; 3. Institute Dante Pazzanese of Cardiology São Paulo, São Paulo, Brazil

Aims: We describe the first-in-human experience with a novel cerebral embolic protection device used during transcatheter aortic valve implantat

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions